Df. Moore et al., ACUTE ARSENIC POISONING - ABSENCE OF POLYNEUROPATHY AFTER TREATMENT WITH 2,3-DIMERCAPTOPROPANESULPHONATE (DMPS), Journal of Neurology, Neurosurgery and Psychiatry, 57(9), 1994, pp. 1133-1135
Two men aged 19 and 21 years ingested Ig and 4 g respectively from 3 k
g of a white crystalline powder that they thought was a substance of a
buse. It was later identified as almost pure arsenic trioxide. Both ha
d nausea and vomiting and one developed acute renal failure. Each was
treated with 2,3-dimercaptopropanesulphonate (DMPS), and made a full r
ecovery with no evidence of prolonged renal or neurological impairment
. The DMPS-arsenic complex is probably associated with lower penetrati
on into the CNS and as a consequence treatment with DMPS may result in
lower acute and chronic neurotoxicity than treatment with the current
ly standard recommended chelating agent;dimercaprol (British Anti-Lewi
site; BAL).